GT: The Podcast

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is by joined by Reena Garg, MD, to discuss next steps for a patient who is having difficulty adhering to his topical medication regimen. With no progression shown on visual field testing, Dr. Singh raises the question of whether the current treatment is appropriate or if the compliance issue warrants exploring a different option such as repeat selective laser trabeculoplasty, drug delivery, or surgery. Dr. Garg weighs in, and later, they compare their opinions with the results of a social media poll of GT’s audience and Dr. Singh shares what he did.

Welcome to GT: The Podcast! In this episode, glaucoma specialists share the approaches and pearls they wish they had discovered sooner, as featured in the November/December 2025 issue of Glaucoma Today. Kateki Vinod, MD, and Won I. Kim, MD, share their reflections on IOP monitoring and how home tonometry has changed their respective practices. Later, Jenny Lu describes age-related neuroretinal alterations and how these changes can mimic glaucomatous damage, as covered in an article by Shuning Li, MD, PhD, and Ying Han, MD, PhD.

Welcome to GT: The Podcast! In this episode, Mohamed M. Khodeiry, MD, MSc, recaps his article, “Glaucoma Intrascleral Tube Surgery,” written with James Richardson-May, MD, and Ahmed Elbably, MSc, FRCS, and featured in the July/August issue of Glaucoma Today. A surgical modification called glaucoma intrascleral tube surgery (GITS) may help address some postoperative complications associated with subconjunctival stent implantation. Dr. Khodeiry discusses the development of GITS, specifics of the surgical technique, early outcomes, and future directions.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Emily Schehlein, MD, and H. George Tanaka, MD, to review a real case from his practice involving a patient with glaucoma with a history of SLT and MIGS. Though the patient’s IOP is at target, she is very unhappy with topical medication. The group discusses the importance of quality of life and weighs possible next steps, including drug delivery, repeat SLT, surgical intervention, or continuing as is. Later, the guests find out what Dr. Singh did, and they compare their opinions with the results of a social media poll of GT’s audience.

I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. Editorially independent content supported with advertising by Glaukos.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of GT’s audience and find out what Dr. Singh did.

Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of Glaucoma Today. IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.

Catherine Johnson, MD, MPH, recaps her article, “Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation,” which was written with Barbara Wirostko, MD, FARVO, and featured in the November/December issue of Glaucoma Today. Home tonometry data are shedding light on SLT’s effect on IOP spikes in the months following laser treatment. This article reviews diurnal IOP fluctuation before and after SLT and discusses the implications of home tonometry in research.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while still leaving options on the table for future treatment. Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience.

Jason Xiao, BS, recaps his article, “Improving the Affordability of Glaucoma Medications,” which was written with Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD, and featured in the May/June issue of Glaucoma Today. Their article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients’ out-of-pocket pharmacy costs.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Monica Ertel, MD, and Mark Gallardo, MD, to review a case from Dr. Singh’s practice. The guests share their perspective on a patient with slowly progressive disease and a history of failed trabeculectomy, and they offer their thoughts on IOP goals and potential treatments. Later, the panelists find out how their colleagues would approach the case based on results of a social media poll of GT’s audience.

Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.

Slow down, take a breath, and get back to basics with glaucoma care. Join moderator I. Paul Singh, MD, and panelists Sarah Van Tassel, MD, and Joseph Panarelli, MD, as they review their priorities for their patient encounters in Glaucoma. Which imaging modalities are most effective? How do their workflows function? And, as new patients become returning patients, how can software solutions such as the ZEISS Glaucoma Workplace help keep your clinic flowing smoothly?